NCT06904859View on ClinicalTrials.gov

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2020

Conditions
Acute Myeloid Leukemia (AML)
Interventions
BIOLOGICAL

TCR-T Cells Injection

The TCR sequences of AML patients were analyzed by next generation sequencing to find the specific TCR clone against leukemia，then TCR gene-modified T cells were infused back into the patients

Trial Locations (1)

Unknown

Shenzhen University General Hospital, Shenzhen

All Listed Sponsors
lead

Shenzhen University General Hospital

OTHER

NCT06904859 - The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter